Showing 2551-2560 of 9078 results for "".
Neotensil®: A Novel, Noninvasive Solution That Reduces the Appearance of Under-Eye Bags
https://practicaldermatology.com/topics/practice-management/neotensil-a-novel-noninvasive-solution-that-reduces-the-appearance-of-under-eye-bags/19058/Neotensil is the only noninvasive solution clinically proven to reduce the appearance of under-eye bags within an hour, with benefits that last up to 16 hours. Doris Day, MD, discusses the benefits of Neotensil, as well as patient selection, staff training and how to incorporate this unique and effeThe Importance of Planning
https://practicaldermatology.com/topics/practice-management/the-importance-of-planning/19082/Failing to plan is planning to fail, say Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions. They tell aesthetic practices how to lay the foundation for success in minimally invasive procedures.The Latest Skin Cancer Developments
https://practicaldermatology.com/conferences/noah-worcester/the-latest-skin-cancer-developments/57062/Darrell S. Rigel, MD, discusses his presentation, “Skin Cancer Update 2026 – What You Need to Know for Your Practice,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Tips for Treating Children
https://practicaldermatology.com/conferences/noah-worcester/tips-for-treating-children/57066/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, discusses her two Alfred L. Weiner lectures on pediatric dermatology from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Raising Awareness of Alpha-Gal Syndrome
https://practicaldermatology.com/conferences/noah-worcester/raising-awareness-of-alpha-gal-syndrome/57060/Stephany Vittitow, MD, discusses her resident lecture, “Alpha-Gal Syndrome: A Review,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.The Noah Family
https://practicaldermatology.com/conferences/noah-worcester/the-noah-family/57061/Amy Spizuoco, DO, explains what makes the Noah Worcester Dermatological Society’s annual meetings special and what she took away from the 2026 Annual Meeting.INTEGUMENT-OLE and What’s Next for Pediatric AD
https://practicaldermatology.com/series/skin-minute/integument-ole-study/56899/Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Journal Club: Combination Therapy With Dupilumab and Upadacitinib
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combination-therapy-with-dupilumab-and-upadacitinib/32408/Neal Bhatia, MD, FAAD, and Ted Lain, MD, MBA, FAAD, discuss the International Journal of Dermatology article “Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis,” and their own experiences with similar treatment strategies.The Importance and Utility of GEP Testing
https://practicaldermatology.com/series/updates-in-skin-cancer/the-importance-and-utility-of-gep-testing/35597/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses gene expression profiling technology and its importance in the diagnosis and prognostication of melanomas.